This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Complexa Inc.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: The Innovative Mind of Diane Jorkasky: Revolutionizing Treatments for FSGS
Introduction: Diane Jorkasky, an accomplished inventor based in Devon, PA, has made significant strides in the field of pharmaceuticals. With her innovative approach, she has contributed to advancements in the treatment of focal segmental glomerulosclerosis (FSGS) through her unique patent, which emphasizes the importance of specific compounds in medical treatments.
Latest Patents: Diane holds a patent for the "Treatment of focal segmental glomerular sclerosis (FSGS) using therapeutically effective oral doses of 10-nitro-9(E)-octadec-9-enoic acid." This patent encompasses various embodiments aimed at pharmaceutical compositions and methodologies for treating diseases like FSGS and pulmonary arterial hypertension. The compositions are formulated with activated fatty acids, including alkyl substituted fatty acids, keto fatty acids, and nitro fatty acids. The primary method entails administering an effective dose of 10-nitro-9(E)-octadec-9-enoic acid to address such serious health conditions.
Career Highlights: Diane Jorkasky's professional journey has been shaped by her commitment to medical innovation. Her work with Complexa Inc. has been pivotal, as she has played a key role in developing therapeutic solutions that can significantly improve patient outcomes.
Collaborations: Throughout her career, Diane has actively engaged in collaborations with various professionals in the pharmaceutical field. Her associations have enriched her understanding of drug development and propelled her inventions toward market readiness.
Conclusion: Diane Jorkasky exemplifies the dedication and creativity of modern inventors. Her patent not only addresses a critical health issue but also highlights the important role that innovative thinking plays in advancing medical treatments. Through her work at Complexa Inc. and her commitment to innovation, Diane continues to make a lasting impact on the healthcare industry.